ロード中...
Attacking malignant cells that survive therapy: Exploiting immunogenic modulation
We have recently defined “immunogenic modulation,” a mechanism whereby malignant cells that survive anticancer therapy, due to sublethal delivery or development of treatment resistance, become nonetheless more sensitive to killing by cytotoxic T lymphocytes. This mechanism can be exploited to identi...
保存先:
主要な著者: | , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Landes Bioscience
2013
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902115/ https://ncbi.nlm.nih.gov/pubmed/24498561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26937 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|